SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab shares are receiving attention following the announcement of a new high-efficiency solar cell that reduces reliance on supply-constrained minerals. While many traders are optimistic about the firm's end-to-end space capabilities and the upcoming Iridium acquisition, others express frustration over share dilution and skepticism regarding the Neutron rocket's development timeline.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending due to a strong fiscal fourth-quarter earnings report that exceeded analyst expectations and featured robust fiscal year 2027 guidance. Traders are reacting positively to the company's substantial order backlog and capacity expansion plans, viewing the firm as a key beneficiary of the ongoing AI data center and electrical infrastructure buildout.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

The community is highly bullish following the final efficacy analysis of the ORIGIN 3 trial, which demonstrated that trutakna met all endpoints including a significant reduction in composite kidney-disease progression events. Traders are focused on the potential for a short squeeze due to high short interest and anticipation for the upcoming supplemental BLA filing.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The index is experiencing significant volatility as investors weigh the Federal Reserve's looming interest rate decision against concerns over AI sector sustainability and rising Treasury yields. While traders are debating the impact of AI development calls and geopolitical tensions, the market has shown a notable resilience, with many participants continuing to favor 'buying the dip' strategies despite the bearish sentiment and macro pressures.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is experiencing significant volatility as traders react to the company's announcement of a $1 billion convertible senior notes offering. While the move is intended to provide capital for growth, community discussion is divided between optimism regarding the company's long-term potential in public safety technology and concerns over future stock dilution and current valuation levels.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending as investors show strong interest in its pending merger with Agility Robotics, a company positioned as a pure-play U.S. humanoid robotics leader backed by major tech firms like NVIDIA and Amazon. Traders are expressing significant bullish sentiment, citing Agility's established commercial deployments and the broader humanoid robotics sector as a high-growth thematic opportunity.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

Semiconductor stocks are facing downward pressure as investors rotate into software and defensive sectors, driven by broad industry debates over the pace of AI infrastructure investment and the potential for a regulatory slowdown in AI development. This volatility is further compounded by cautious sentiment ahead of the upcoming Federal Reserve policy decision and rising Treasury yields.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is trending as traders speculate on potential upside from product releases, strong earnings performance, and the company's expansion into AI-powered workstations. While some participants express bullish sentiment regarding the stock's turnaround and market positioning, others debate the company's valuation and long-term competitiveness in the gaming hardware sector.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending primarily due to the release of positive Phase 3 topline results for its plozasiran studies in patients with severe hypertriglyceridemia, which demonstrated significant and durable triglyceride reduction along with a reduction in acute pancreatitis events. The community discussion is focused on the potential for commercialization, the impact of these results on the competitive landscape with other therapies, and the broader validation of the company's RNAi platform.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is currently attracting attention as traders track developments in the photonics and semiconductor space, with significant interest focused on its recent $30 million CHIPS Act letter of intent and potential for future government and commercial contracts. While some investors express frustration over the stock's recent volatility and lack of major commercial sales disclosures, others maintain a long-term bullish thesis based on the company's technology, government validation, and strategic hires.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ICOI  I bought $IMRA July 3 and am up about 5%. Doesn&#39;t matter how juicy the dividend is, if the share price drops.$ICOI is down a tiny bit. $IMST is actually negative by close to 10%. Undecided as to whether I&#39;ll sell any soon or wait to see if they improve. (Got each on July 3)

EMJ capltal

StockTwits Web

Bitwise COIN Option Income Strategy ETF

Bitwise MARA Option Income Strategy ETF

Bitwise MSTR Option Income Strategy ETF

 July 3 and am up about 5%. Doesn't matter how juicy the dividend is, if the share price drops.

 is actually negative by close to 10%. Undecided as to whether I'll sell any soon or wait to see if they improve. (Got each on July 3)